Belgravia Capital International Inc (OTCMKTS: BLGVF) has announced that it has made senior additions to the management team. The company has appointed Dr. Shoaib Sheikh to join the team as a medical advisor and Mr. Jason Batista who is coming on board as Director of Corporate Development.

Dr. Shoaib Sheikh, who is a physician, is a qualified and experienced laparoscopic surgeon. He is a member of American Association of Hand Surgeons where he serves as the chairman of the Technology Committee. Dr. Sheikh also attended the Harvard Business School where he studied the management of health care delivery as well as high performance healthcare leadership.

While acknowledging the appointments, Belgravia Capital President and Chief Executive Officer Mr. Mehdi Azodi said the company stands to benefit immensely from Dr. Sheikh’s leadership capabilities. He added that as a result, the company will be in a better position to execute on its planned commercial developments in the Cannabidiol sector, where added that the company is making significant and steady steps. Dr. Sheikh will be joining Dr. Sam Hanna who is also on the advisory committee.

Dr. Hanna is a well-known Canadian dermatologist who is currently assisting the company to its opportunities in the commercial Cannabidiol industry. Mr. Mehdi said that they will soon be providing details concerning the Belgravia-led and Belgravia-financed dermatological product developments in both the medical and cosmetic areas.

Mr. Jason Batista is trained in financial management and several advanced courses in the field of financial planning. He has been working for two investment dealers owned by the Canadian bank as an investment advisor. He has held this position since 2002. Mr. Jason will be working with the company’s CEO in the review and management of the company’s investment portfolio.

The company currently holds an interest in water royalties that may be earned from selling water rights in New Mexico. The company holds the interest through a royalty streaming division. The company has announced that it will be providing full details of water royalties in the third quarter of 2018.

Belgravia has a business model which mainly involves developing commercial opportunities in the medical cannabis sector. The business model involve making short term investments in the field of medical cannabis, developing the concept of CBD medical products as well as making investment in other fields which are not related to cannabis but have potential opportunities.